Focus on Pancreatic Cancer

 

Photo by Cancer Type

“In situations when the cancer has progressed following surgery, options like Abraxane can help prolong a patient’s life

FDA Approves Abraxane for Late-stage Pancreatic Cancer

The U.S. Food and Drug Administration has expanded the approved uses of Abraxane (paclitaxel protein-bound particles for injectable suspension, albumin-bound) to treat patients with late-stage (metastatic) pancreatic cancer.

Read More

 

Photo by Cancer Type

Chemotherapy Regimen Extends Survival in Advanced Pancreatic Cancer

A four-drug chemotherapy regimen has produced the longest improvement in survival ever seen in a phase III clinical trial of people with metastatic pancreatic cancer, one of the deadliest types of cancer.

Read More

 

Photo by Cancer Type

Surprise Finding: Pancreatic Cancers Progress Slowly

Pancreatic cancer develops and spreads much more slowly than scientists have thought, according to new research from Johns Hopkins investigators. The finding indicates that there is a potentially broad window for diagnosis and prevention of the disease.

Read More